Clinical trials
Uterine Cervical Dysplasia trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
70 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2005 | 1 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 3 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 4 |
| 2015 | 8 |
| 2016 | 4 |
| 2017 | 8 |
| 2018 | 5 |
| 2019 | 7 |
| 2020 | 6 |
| 2021 | 6 |
| 2022 | 4 |
| 2023 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 70 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Huazhong University of Science and Technology | 5 |
| Genexine, Inc. | 3 |
| Jun Zhang | 3 |
| Lei Li | 3 |
| Brookdale University Hospital Medical Center | 2 |
| Erasmus Medical Center | 2 |
| University Medical Center Groningen | 2 |
| University of Aarhus | 2 |
| University of Copenhagen | 2 |
| Alkü Alanya Education and Research Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Uterine Cervical Dysplasia | 70 |
| Uterine Cervical Neoplasms | 27 |
| Papillomavirus Infections | 10 |
| Neoplasms | 4 |
| Squamous Intraepithelial Lesions | 4 |
| Atypical Squamous Cells of the Cervix | 3 |
| Persistent Infection | 3 |
| Acquired Immunodeficiency Syndrome | 2 |
| Dermatitis, Seborrheic | 2 |
| Disease | 2 |
Trials
Showing 26 to 50 of 70. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.